Key Sessions
Craig Lipset
NextGen Decentralized: Stabilizing DCT 1.0, Advancing DCT 2.0
Decentralized Trials & Research Alliance (DTRA)
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day One - EST/EDT (Eastern Daylight, GMT-4)
keyboard_arrow_leftSearch & Filter
search
Formats
Day One - EST/EDT (Eastern Daylight, GMT-4)
search
Formats
8:00am - 8:50am50 mins
Morning Coffee and Registration
8:50am - 9:00am10 mins
Chairperson’s Opening Remarks
9:00am - 9:30am30 mins
NextGen Decentralized: Stabilizing DCT 1.0, Advancing DCT 2.0
- Craig Lipset - Founder & Advisor, Clinical Innovation Partners, Co-Chair, Decentralized Trials & Research Alliance (DTRA)
9:30am - 10:00am30 mins
Keynote Spotlight Presentation: Available
10:00am - 10:30am30 mins
Framework on DCT and CSL Experiences
- Liz Quinlan - Associate Director, eClinical Technology, CSL Behring
10:30am - 11:00am30 mins
Lessons Learned from the First Decentralized Digital Therapeutic Study
- Mary Slomkowski - Executive/Senior Director, Clinical Management, Otsuka Pharmaceutical Development & Commercialization
11:00am - 11:30am30 mins
Morning Coffee Break and Networking
11:30am - 12:00pm30 mins
EU Recommendations on Decentralised Elements in Clinical Trials
- Ditte Zerlang Christensen - EU Project Manager, Special Advisor, Danish Medicines Agency
12:00pm - 12:30pm30 mins
Data Dump: Which Metrics Matter and Which are Just Garbage for DCT Enrollment
- Dan Brenner - CEO, 1nHealth
12:30pm - 1:30pm60 mins
Lunch and Networking
1:30pm - 2:00pm30 mins
Feedback and Experience from a Patient that has Participated on a DCT Trial
- Jen Horonjeff - Founder and CEO, Savvy Cooperative
2:00pm - 2:40pm40 mins
PANEL: Sharing Individual Research Results in Decentralized Studies: A Participant’s Perspective, a Toolkit, and Case Study in Alzheimer’s Disease
- Jamie Tyrone - Research Participant, Patient Advocate and Author "Fighting for My Life - How to Thrive in the Shadow of Alzheimer's", Beating Alzheimer's By Embracing Science (B.A.B.E.S.)
- Barbara Bierer - MD, Multi-Regional Trial Center with Harvard and Brigham (MRCT)
- Sarah Walter - Alzheimer's Clinical Trial Consortium (ACTC) and Alzheimer's Therapeutic Research Institute (ATRI), University of Southern California (USC)
2:40pm - 3:10pm30 mins
CISCRP Survey on Patient Attitudes and Experiences with Remote and Virtual Solutions in Clinical Trials
- Jessica Cronin - Senior Project Manager, Research Services, Center for Information & Study on Clinical Research Participation (CISCRP)
3:10pm - 3:40pm30 mins
Spotlight Presentation: mdgroup
- Caroline Jackson - Executive Vice President, Patient Services, MD Group
3:40pm - 4:10pm30 mins
Afternoon Coffee Break and Networking
4:10pm - 4:40pm30 mins
Measuring the Impact of DCT on Patient Enrollment Diversity
- Zak Smith - Project Manager and Data Scientist, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
4:40pm - 5:10pm30 mins
Experience of Decentralize Trials –If Successful in Increasing the Diversity of Participation
- Arturo Loaiza-Bonilla - Enterprise Director of Research, Cancer Treatment Centers of America
5:10pm - 5:50pm40 mins
PANEL: How to Maintain the Human Connection and Foster Engagement and Diversity with DCT
- Tracey Robertson - Global Clinical Development & Operations – Head Patient & Site Engagement Capabilities, Boehringer Ingelheim
- Melissa Brown - Senior Manager, CSL Behring Biotherapies
- Sarah Walter - Alzheimer's Clinical Trial Consortium (ACTC) and Alzheimer's Therapeutic Research Institute (ATRI), University of Southern California (USC)
- Jen Yip - Associate Director, Digital Trials & Patient Engagement, Novartis
5:50pm - 6:50pm60 mins
Drinks Reception
Filter
Formats
Choose Day